The Valley Desk

NCT00068393 · Interventional trial

Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell Carcinoma

Overall registry status Completed

Phase 2

Conditions Metastatic Renal Cell Carcinoma, Renal Cell Carcinoma With Sarcomatoid Features

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov